Tiago Cordeiro Felismino, Chief and Upper Gastrointestinal Oncology at A.C.Camargo Cancer Center, shared on LinkedIn about a recent paper by R. P. Riechelmann et al. published on ESMO:
“The rising cost of new cancer drugs restricts access worldwide. In our article, we propose dose optimization and drug substitution strategies for gastrointestinal and neuroendocrine tumors in low- and middle-income countries, aiming to expand access and reduce disparities.”
